IL2 and neoplasm: To overcome these limitations, different strategies have been tested for melanoma such as the combination of TILs with cytokines (IFN-α, IFN-β, IL-2, IL-7, IL-12, IL-15, IL-21, and TNF-α) or with vaccines (fowlpox-based vaccine, GM-CSF—producing tumor-based vaccine).